Coni, S., Mancuso, A. B., Di Magno, L., Sdruscia, G., Manni, S., Serrao, S. M., . . . Canettieri, G. (2017). Corrigendum: Selective targeting of HDAC1/2 elicits anticancer effects through Gli1 acetylation in preclinical models of SHH Medulloblastoma. Sci Rep.
Chicago Style CitationConi, Sonia, et al. "Corrigendum: Selective Targeting of HDAC1/2 Elicits Anticancer Effects Through Gli1 Acetylation in Preclinical Models of SHH Medulloblastoma." Sci Rep 2017.
Cita MLAConi, Sonia, et al. "Corrigendum: Selective Targeting of HDAC1/2 Elicits Anticancer Effects Through Gli1 Acetylation in Preclinical Models of SHH Medulloblastoma." Sci Rep 2017.
Atenció: Aquestes cites poden no estar 100% correctes.